Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations ...

David Liu, Joel Habener, and Alberto Ascherio are among recipients of this year's six Breakthrough Prizes, the "Oscars of ...

We want wide, fast, and affordable access for our new antiviral. It might sound counterintuitive, but a patent will help us ...

Stock analysts at Zacks Small Cap issued their Q1 2025 earnings per share (EPS) estimates for Cocrystal Pharma in a research ...

Equities research analysts at Zacks Small Cap issued their Q3 2025 earnings per share (EPS) estimates for Cocrystal Pharma in a research report issued to clients and investors on Tuesday, April 1st.

Structure-based drug design is the design and optimization ... ultimately eliciting a medical effect. A novel antiviral targeting the SARS-CoV-2 PLpro protease shows strong efficacy in a mouse ...

In the search for better ways of tackling the debilitating condition, Australian researchers have zeroed in on a newly discovered chink in the virus’s armour.